Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 17/20 | 0.73 |
| ▸ | PDE4B | Q07343 | 11/20 | 0.73 |
| ▸ | PDE4C | Q08493 | 11/20 | 0.73 |
| ▸ | PDE4D | Q08499 | 11/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | VEGFA | P15692 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | PDE5A | O76074 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4197597 | 1.00 | PDE4A (0.73) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL9341618 | 0.85 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL13439292 | 0.85 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL3547095 | 0.85 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL4466602 | 0.82 | PDE4A (0.74) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL4458628 | 0.82 | PDE4A (0.74) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL3539960 | 0.82 | PDE4A (0.74) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL559874 | 0.81 | PDE4A (0.54) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL13677651 | 0.81 | PDE4A (0.74) | PDE4APDE4BPDE4CPDE4DMAPK1 | |
| SCHEMBL3897079 | 0.81 | PDE4A (0.74) | PDE4APDE4BPDE4CPDE4DMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1841425-A4 | PHENYL-SUBSTITUTED PYRROLIDONES | IRM LLC A DELWARE LTD LIABILIT (BM) | 2009-02-18 | — | — | EP | disclosed |
| US-20080287516-A1 | Phenyl-Substituted Pyrrolidones | IRM LLC (BM) | 2008-11-20 | — | — | US | disclosed |
| US-20080287516-A1 | Phenyl-Substituted Pyrrolidones | IRM LLC (BM) | 2008-11-20 | — | — | US | disclosed |
| CN-101115481-A | Phenyl-substituted pyrrolidones | IRM LLC (BM) | 2008-01-30 | — | — | CN | disclosed |
| EP-1841425-A2 | PHENYL-SUBSTITUTED PYRROLIDONES | IRM LLC A Delware Limited Liability Company (BM) | 2007-10-10 | — | — | EP | disclosed |
| EP-1841424-A2 | SYNTHESIS OF ARYL PYRROLIDONES | IRM, LLC (BM) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006081554-A2 | PHENYL-SUBSTITUTED PYRROLIDONES | IRM LLC (BM) | 2006-08-03 | — | — | WO | disclosed |
| WO-2006081562-A2 | SYNTHESIS OF ARYL PYRROLIDONES | IRM LLC (BM) | 2006-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287516-A1 | Phenyl-Substituted Pyrrolidones | MALT1, FKBP5, PREP | PDE4A 1181/4885PDE4B 1238/4885PDE4C 1261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.